Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect

Teng Moua; Aahd Kubbara; Paul Novotny; Jennifer L Ridgeway; Andrew H Limper; Jay H Ryu; Matthew M Clark; Roberto Benzo

doi:10.1183/23120541.00011-2021

Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect

ERJ Open Res. 2021 Mar 8;7(1):00011-2021. doi: 10.1183/23120541.00011-2021. eCollection 2021 Jan.

Authors

Teng Moua¹, Aahd Kubbara¹, Paul Novotny², Jennifer L Ridgeway³, Andrew H Limper^{1

3}, Jay H Ryu¹, Matthew M Clark⁴, Roberto Benzo¹

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
² Dept of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
³ Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
⁴ Dept of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Abstract

Patient-reported outcomes in fibrotic interstitial lung disease may be additionally predicted by novel assessments of self-management ability and affect https://bit.ly/3iwP5M2.

Grants and funding

K24 HL138150/HL/NHLBI NIH HHS/United States